These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

382 related items for PubMed ID: 38876358

  • 1. Lipid nanoparticle (LNP) mediated mRNA delivery in cardiovascular diseases: Advances in genome editing and CAR T cell therapy.
    Soroudi S, Jaafari MR, Arabi L.
    J Control Release; 2024 Aug; 372():113-140. PubMed ID: 38876358
    [Abstract] [Full Text] [Related]

  • 2. Developing Biodegradable Lipid Nanoparticles for Intracellular mRNA Delivery and Genome Editing.
    Qiu M, Li Y, Bloomer H, Xu Q.
    Acc Chem Res; 2021 Nov 02; 54(21):4001-4011. PubMed ID: 34668716
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. AGILE platform: a deep learning powered approach to accelerate LNP development for mRNA delivery.
    Xu Y, Ma S, Cui H, Chen J, Xu S, Gong F, Golubovic A, Zhou M, Wang KC, Varley A, Lu RXZ, Wang B, Li B.
    Nat Commun; 2024 Jul 26; 15(1):6305. PubMed ID: 39060305
    [Abstract] [Full Text] [Related]

  • 8. Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components.
    Kazemian P, Yu SY, Thomson SB, Birkenshaw A, Leavitt BR, Ross CJD.
    Mol Pharm; 2022 Jun 06; 19(6):1669-1686. PubMed ID: 35594500
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparative analysis of lipid Nanoparticle-Mediated delivery of CRISPR-Cas9 RNP versus mRNA/sgRNA for gene editing in vitro and in vivo.
    Walther J, Porenta D, Wilbie D, Seinen C, Benne N, Yang Q, de Jong OG, Lei Z, Mastrobattista E.
    Eur J Pharm Biopharm; 2024 Mar 06; 196():114207. PubMed ID: 38325664
    [Abstract] [Full Text] [Related]

  • 12. Influence of ionizable lipid tail length on lipid nanoparticle delivery of mRNA of varying length.
    Mrksich K, Padilla MS, Joseph RA, Han EL, Kim D, Palanki R, Xu J, Mitchell MJ.
    J Biomed Mater Res A; 2024 Sep 06; 112(9):1494-1505. PubMed ID: 38487970
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Recent advances in lipid nanoparticles for delivery of nucleic acid, mRNA, and gene editing-based therapeutics.
    Mukai H, Ogawa K, Kato N, Kawakami S.
    Drug Metab Pharmacokinet; 2022 Jun 06; 44():100450. PubMed ID: 35381574
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. EGFR-targeted ionizable lipid nanoparticles enhance in vivo mRNA delivery to the placenta.
    Geisler HC, Ghalsasi AA, Safford HC, Swingle KL, Thatte AS, Mukalel AJ, Gong N, Hamilton AG, Han EL, Nachod BE, Padilla MS, Mitchell MJ.
    J Control Release; 2024 Jul 06; 371():455-469. PubMed ID: 38789090
    [Abstract] [Full Text] [Related]

  • 20. Ionizable Lipid Nanoparticles for Therapeutic Base Editing of Congenital Brain Disease.
    Palanki R, Bose SK, Dave A, White BM, Berkowitz C, Luks V, Yaqoob F, Han E, Swingle KL, Menon P, Hodgson E, Biswas A, Billingsley MM, Li L, Yiping F, Carpenter M, Trokhan A, Yeo J, Johana N, Wan TY, Alameh MG, Bennett FC, Storm PB, Jain R, Chan J, Weissman D, Mitchell MJ, Peranteau WH.
    ACS Nano; 2023 Jul 25; 17(14):13594-13610. PubMed ID: 37458484
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.